160 related articles for article (PubMed ID: 19252473)
1. Atypical and malignant hidradenomas: a histological and immunohistochemical study.
Nazarian RM; Kapur P; Rakheja D; Piris A; Duncan LM; Mihm MC; Hoang MP
Mod Pathol; 2009 Apr; 22(4):600-10. PubMed ID: 19252473
[TBL] [Abstract][Full Text] [Related]
2. [Malignant nodular hidradenoma and multiple nodular hidradenomas in a hypogonadic patient].
Toulemonde A; Croue A; Rodien P; Verret JL
Ann Dermatol Venereol; 2006 Dec; 133(12):1005-8. PubMed ID: 17185934
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor gene status by fluorescence in situ hybridization in malignant, atypical, and benign hidradenomas.
Piris A; Scopsi L; Clemente C; Cetti Serbelloni F; Mihm MC; Hoang MP
Am J Dermatopathol; 2010 Aug; 32(6):586-92. PubMed ID: 20534988
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation.
Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M
Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064
[TBL] [Abstract][Full Text] [Related]
5. A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.
Dias-Santagata D; Lam Q; Bergethon K; Baker GM; Iafrate AJ; Rakheja D; Hoang MP
Mod Pathol; 2011 Jul; 24(7):974-82. PubMed ID: 21423156
[TBL] [Abstract][Full Text] [Related]
6. Cytologic features of hidradenoma in fine needle aspiration biopsies.
Dubb M; Michelow P
Acta Cytol; 2009; 53(2):179-82. PubMed ID: 19365971
[TBL] [Abstract][Full Text] [Related]
7. Giant hidradenocarcinoma: a report of malignant transformation from nodular hidradenoma.
Lim SC; Lee MJ; Lee MS; Kee KH; Suh CH
Pathol Int; 1998 Oct; 48(10):818-23. PubMed ID: 9788267
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and genomic copy number variation analysis in nodular hidradenoma and hidradenocarcinoma with focus on prognostically important features.
Jiang H; Shah K; Reed KA; Gliem TJ; Guo R
Hum Pathol; 2022 Nov; 129():103-112. PubMed ID: 36075320
[TBL] [Abstract][Full Text] [Related]
9. [Case of clear cell hidradenoma with mucinous metaplasia in the forehead--immunohistochemical analysis of the mucin].
Ishida M; Kojima F; Kushima R; Kakutani A; Okabe H
Rinsho Byori; 2006 Aug; 54(8):781-4. PubMed ID: 16989395
[TBL] [Abstract][Full Text] [Related]
10. Hidradenocarcinoma: a histological and immunohistochemical study.
Ko CJ; Cochran AJ; Eng W; Binder SW
J Cutan Pathol; 2006 Nov; 33(11):726-30. PubMed ID: 17083691
[TBL] [Abstract][Full Text] [Related]
11. Management of a hidradenoma with Mohs micrographic surgery.
House NS; Helm KF; Maloney ME
J Dermatol Surg Oncol; 1994 Sep; 20(9):619-22. PubMed ID: 8089362
[TBL] [Abstract][Full Text] [Related]
12. p53 expression in two cases of spiradenocarcinomas.
Fernández-Aceñero MJ; Manzarbeitia F; Mestre MJ; Requena L
Am J Dermatopathol; 2000 Apr; 22(2):104-7. PubMed ID: 10770428
[TBL] [Abstract][Full Text] [Related]
13. Nodular hidradenoma. A report of three cases and review of the literature.
Stratigos AJ; Olbricht S; Kwan TH; Bowers KE
Dermatol Surg; 1998 Mar; 24(3):387-91. PubMed ID: 9537017
[TBL] [Abstract][Full Text] [Related]
14. Spiradenocylindrocarcinoma: a malignant hybrid tumor.
Carlsten JR; Lewis MD; Saddler K; Reilly P; Pan T; Gnepp DR; Robinson-Bostom L
J Cutan Pathol; 2005 Feb; 32(2):166-71. PubMed ID: 15606677
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation in skin tumors with ductal differentiation: patterns and diagnostic applications.
Pozo L; Camacho F; Rios-Martin JJ; Diaz-Cano SJ
J Cutan Pathol; 2000 Jul; 27(6):292-7. PubMed ID: 10885405
[TBL] [Abstract][Full Text] [Related]
16. Poroid hidradenoma. A case presentation.
Whitmore RM; Anderson CJ; Piper T
J Am Podiatr Med Assoc; 1998 Oct; 88(10):510-3. PubMed ID: 9791957
[TBL] [Abstract][Full Text] [Related]
17. Value of Immunohistochemistry to Differentiate Digital Papillary Adenocarcinoma From Acral Hidradenoma With Papillary Structures.
Xavier-Júnior JCC; Camilo-Júnior DJ; Carneiro Dias AL; Marques Ferreira PP; Abdalla Filho AR; Brenn T
Am J Dermatopathol; 2022 Nov; 44(11):843-845. PubMed ID: 36066118
[TBL] [Abstract][Full Text] [Related]
18. Hidradenoma papilliferum with a ductal carcinoma in situ component: case report and review of the literature.
Vazmitel M; Spagnolo DV; Nemcova J; Michal M; Kazakov DV
Am J Dermatopathol; 2008 Aug; 30(4):392-4. PubMed ID: 18645314
[TBL] [Abstract][Full Text] [Related]
19. Nodular hidradenoma and hidradenocarcinoma. A 10-year review.
Hernández-Pérez E; Cestoni-Parducci R
J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):15-20. PubMed ID: 2984259
[TBL] [Abstract][Full Text] [Related]
20. Histological findings and pathologic diagnosis of spiradenocarcinoma: A case series and review of the literature.
Huang A; Vyas NS; Mercer SE; Phelps RG
J Cutan Pathol; 2019 Apr; 46(4):243-250. PubMed ID: 30588645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
